Pulling SEC filings + quote and writing the call…
EBS
Emergent BioSolutions Inc.
Next earnings Aug 4, 2026 · consensus $0.11 EPS, $179M rev
Last earnings +3.0% on 2026-04-30
$8.00
▼ -1.72%$8.00▲ +28.21%
over 1Y
L $5.63EODHDH $13.90
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-1.7%
1W-4.6%
1M-0.7%
3M-1.0%
YTD-36.1%
1Y+28.2%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 6 analysts
Buy
Undemanding valuation (P/E 8.6); but revenue fell -28.8% YoY.
The read
Sources: SEC EDGAR (CIK 0001367644, latest 10-Q filed 2026-05-01) · EODHD · as of 6/22/2026, 1:32:13 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.